GlassScriptPhysician profile
David M Heckler
NPI 1407878275
$2,118.97
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $350 · 2021: $557 · 2022: $207 · 2023: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $562.60 | 2021-2023 | |
| Novo Nordisk INC | $267.38 | 2019-2023 | Ozempic |
| Allergan, INC. | $246.57 | 2019-2020 | |
| Amgen INC. | $224.71 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $161.98 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.06 | 2019-2022 | |
| Pfizer INC. | $128.35 | 2019-2023 | |
| Daiichi Sankyo INC. | $89.63 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $35.37 | 2020-2021 | |
| Amarin Pharma, INC. | $31.94 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $30.33 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $29.98 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.57 | 2019 | |
| Abbott Laboratories | $20.13 | 2023 | Freestyle Libre 2 |
| Philips North America LLC | $19.89 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.56 | 2019 | |
| Merck Sharp & Dohme LLC | $17.77 | 2019 | |
| Gilead Sciences, INC. | $16.28 | 2019 | |
| Lilly USA, LLC | $15.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Heckler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.